Published in PLoS One on May 05, 2014
Discovery of a regioselectivity switch in nitrating P450s guided by molecular dynamics simulations and Markov models. Nat Chem (2016) 0.81
Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G. Afr Health Sci (2015) 0.76
Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62. PLoS One (2016) 0.75
A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1. BMC Genomics (2015) 0.75
In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β-dihydroexemestane. Pharmacol Res Perspect (2017) 0.75
Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins (2006) 22.80
A method to identify protein sequences that fold into a known three-dimensional structure. Science (1991) 14.08
Qinghaosu (artemisinin): an antimalarial drug from China. Science (1985) 4.95
The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol (1993) 4.92
Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. Chem Rev (2004) 4.25
Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem (1992) 3.91
Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev (2002) 2.83
Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol (2002) 1.87
Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: possible role of the hydroxy amino acid in oxygen activation. Proc Natl Acad Sci U S A (1989) 1.75
High throughput docking for library design and library prioritization. Proteins (2001) 1.40
Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver. Arch Biochem Biophys (2000) 1.32
Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution. Mol Pharmacol (2010) 1.32
Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat Prod Rep (2007) 1.25
New AMBER force field parameters of heme iron for cytochrome P450s determined by quantum chemical calculations of simplified models. J Comput Chem (2005) 1.17
Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. J Phys Chem B (2008) 1.16
Functional characterization of 26 CYP2B6 allelic variants (CYP2B6.2-CYP2B6.28, except CYP2B6.22). Pharmacogenet Genomics (2010) 0.99
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine. Malar J (2010) 0.99
Monospecific antipeptide antibody to cytochrome P-450 2B6. Drug Metab Dispos (1999) 0.98
Functional characterization of CYP2B6 allelic variants in demethylation of antimalarial artemether. Drug Metab Dispos (2011) 0.96
Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants. Drug Metab Dispos (2008) 0.89
Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods. J Mol Model (2011) 0.85
Studies of binding modes of (S)-mephenytoin to wild types and mutants of cytochrome P450 2C19 and 2C9 using homology modeling and computational docking. Pharm Res (2004) 0.81
Determination of ligand-binding sites on proteins using long-range hydrophobic potential. Biol Pharm Bull (2008) 0.81
Evaluation of the searching abilities of HBOP and HBSITE for binding pocket detection. J Comput Chem (2009) 0.80
Regioselectivity of CYP2B6: homology modeling, molecular dynamics simulation, docking. J Mol Model (2002) 0.80
Subtle structural changes in tetrahydroquinolines, a new class of nonsteroidal selective androgen receptor modulators, induce different functions. J Chem Inf Model (2012) 0.78
Prediction of three-dimensional structures and structural flexibilities of wild-type and mutant cytochrome P450 1A2 using molecular dynamics simulations. J Mol Graph Model (2016) 0.76
Investigation of substrate recognition for cytochrome P450 1A2 mediated by water molecules using docking and molecular dynamics simulations. J Mol Graph Model (2017) 0.75